After progression on osimertinib, do you recommend overlapping TKI with 2nd line chemotherapy to avoid accelerated disease progression?

Do you recommend overlapping TKI with 2nd line chemotherapy (or chemo-IO) for EGFR+ NSCLC to avoid accelerated disease progression after progression on TKI?

• No, I stop TKI and start chemotherapy after a washout period
• No, I stop TKI and start chemotherapy without a washout period
• Yes, I continue TKI through the first cycle of chemotherapy and then discontinue the TKI
• Other